Parameters | Total patients (n = 817) | Developed ACLF | LT-free 90-day mortality in ACLF group | ||||
---|---|---|---|---|---|---|---|
Yes (n = 371) | No (n = 446) | P value | Yes (n = 112) | No (n = 259) | P value | ||
Age (y) | 54 (42–63) | 55 ± 14 | 51 (37–61) | < 0.001 | 57 ± 14 | 55 ± 14 | 0.351 |
Gender (male, %) | 596 (72.9) | 308 (83.0) | 288 (64.6) | < 0.001 | 95 (84.8) | 213 (82.2) | 0.652 |
Alcohol user, n (%) | 281 (34.4) | 159 (42.9) | 122 (27.4) | < 0.001 | 43 (38.4) | 116 (44.8) | 0.304 |
Cirrhosis, n (%) | 378 (46.3) | 191 (51.5) | 187 (41.9) | 0.007 | 76 (67.9) | 115 (44.4) | < 0.001 |
Chronic liver diseases, n (%) | |||||||
Primary hepatic carcinoma | 30 (3.7) | 23 (6.2) | 7 (1.6) | < 0.001 | 14 (12.5) | 9 (3.5) | 0.002 |
Chronic hepatitis B | 490 (60.0) | 225 (60.7) | 265 (59.4) | 0.774 | 74 (66.1) | 151 (58.3) | 0.167 |
Chronic hepatitis C | 36 (4.4) | 12 (3.2) | 24 (5.4) | 0.171 | 4 (3.6) | 8 (3.1) | 0.759 |
Fatty liver disease | 94 (11.5) | 56 (15.1) | 38 (8.5) | 0.004 | 13 (11.6) | 43 (16.6) | 0.269 |
Alcoholic liver disease | 152 (18.6) | 77 (20.8) | 75 (16.8) | 0.176 | 18 (16.1) | 59 (22.8) | 0.164 |
Autoimmune liver disease | 34 (4.2) | 6 (1.6) | 28 (6.3) | 0.001 | 2 (1.8) | 4 (1.5) | 0.997 |
Schistosomiasis | 18 (2.2) | 13 (3.5) | 5 (1.1) | 0.029 | 3 (2.7) | 10 (3.9) | 0.762 |
Cirrhosis with unknown factor | 37 (4.5) | 12 (3.2) | 25 (5.6) | 0.128 | 3 (2.7) | 9 (3.5) | 0.998 |
Clinical complications, n (%) | |||||||
Ascites | 169 (20.7) | 149 (40.2) | 20 (4.5) | < 0.001 | 75 (67.0) | 74 (28.6) | < 0.001 |
Bacterial infection | 206 (25.2) | 196 (52.8) | 10 (2.2) | < 0.001 | 100 (89.3) | 96 (37.1) | < 0.001 |
Hepatic encephalopathy | 49 (6.0) | 49 (13.2) | 0 | < 0.001 | 42 (37.5) | 7 (2.7) | < 0.001 |
Gastrointestinal haemorrhage | 22 (2.7) | 20 (5.4) | 2 (0.4) | < 0.001 | 12 (10.7) | 8 (3.1) | 0.005 |
Liver function, coagulation indicators and other related laboratory examinations | |||||||
ALT, U/L | 267 (56-1000) | 717 (154–1455) | 117 (38–549) | < 0.001 | 614 (153–1408) | 762 (161–1479) | 0.356 |
AST, U/L | 158 (56–615) | 406 (147–1089) | 77 (38–218) | < 0.001 | 391 (163–1237) | 414 (136–1055) | 0.810 |
ALP, U/L | 134 (97–181) | 154 (122–198) | 114 (82–159) | < 0.001 | 153 (121–196) | 155 (122–199) | 0.786 |
GGT, U/L | 117 (59–217) | 112 (69–195) | 120 (51–233) | 0.955 | 99 (57–140) | 123 (71–235) | 0.003 |
Cholinesterase, U/L | 4701 (3050–6668) | 3416 (2354–4709) | 6135 (4335–7843) | < 0.001 | 2737 (1965–3898) | 3758 (2537–5018) | < 0.001 |
TBA, µmol/L | 95 (17–179) | 169 (112–225) | 23 (8–83) | < 0.001 | 178 (130–232) | 166 (105–224) | 0.128 |
Tbil, µmol/L | 76 (21–217) | 239 (144–373) | 23 (14–58) | < 0.001 | 359 (184–489) | 216 (133–313) | < 0.001 |
Dbil, µmol/L | 53 (10–167) | 178 (106–275) | 12 (6–42) | < 0.001 | 257 (125–331) | 169 (93–230) | < 0.001 |
Total protein, g/L | 66 (61–72) | 63 ± 8 | 69 ± 8 | < 0.001 | 61 ± 8 | 64 ± 8 | < 0.001 |
Albumin, g/L | 36 ± 6 | 33 ± 5 | 38 ± 6 | < 0.001 | 31 ± 5 | 33 ± 5 | < 0.001 |
PTA, % | 80 (58–98) | 56 (42–78) | 92 (78–102) | < 0.001 | 38 (28–54) | 65 (50–84) | < 0.001 |
INR | 1.16 (1.01–1.45) | 1.49 (1.17–1.88) | 1.06 (0.99–1.17) | < 0.001 | 2.05 (1.56–2.74) | 1.33 (1.11–1.65) | < 0.001 |
PT, s | 15 (13–18) | 18 (15–22) | 13.8 (13.1–14.9) | < 0.001 | 23 (19–29) | 16 (14–19) | < 0.001 |
Creatinine, µmol/L | 64.0 (54.2–74.8) | 65.2 (54.3–77.6) | 63.3 (54.2–73.5) | 0.067 | 69.5 (54.1–88.2) | 63.3 (54.3–75.0) | 0.024 |
Glucose, mmol/L | 5.21 (4.55–6.48) | 5.42 (4.39–7.09) | 5.16 (4.65–6.14) | 0.276 | 5.39 (4.10–7.04) | 5.43 (4.53–7.10) | 0.196 |
WBC, 109/L | 5.52 (4.22–7.09) | 6.06 (4.56–8.20) | 5.11 (4.08–6.40) | < 0.001 | 6.72 (5.07–10.29) | 5.76 (4.35–7.72) | 0.001 |
Haemoglobin, g/L | 133 (119–147) | 129 (115–145) | 135 (121–148) | < 0.001 | 128 (110–141) | 129 (116–146) | 0.115 |
Platelet, 109/L | 135 (90–186) | 114 (78–163) | 151 (104–205) | < 0.001 | 94 (71–141) | 124 (84–169) | 0.001 |
Baseline lipid levels | |||||||
Cholesterol, mmol/L | 3.44 (2.61–4.27) | 2.72 (2.04–3.45) | 3.95 (3.32–4.70) | < 0.001 | 2.03 (1.41–2.63) | 2.99 (2.42–3.64) | < 0.001 |
Triacylglycerol, mmol/L | 1.36 (0.91–2.11) | 1.58 (1.10–2.38) | 1.17 (0.81–1.76) | < 0.001 | 1.30 (0.99–1.74) | 1.81 (1.20–2.66) | < 0.001 |
ApoA, g/L | 0.67 (0.29–1.05) | 0.28 (0.16–0.50) | 0.97 (0.73–1.23) | < 0.001 | 0.19 (0.08–0.28) | 0.35 (0.21–0.57) | < 0.001 |
ApoB, g/L | 0.85 (0.65–1.15) | 0.92 (0.61–1.24) | 0.82 (0.66–1.06) | 0.018 | 0.71 (0.49-1.00) | 1.00 (0.69–1.34) | < 0.001 |
HDL-C, mmol/L | 0.58 (0.18–1.07) | 0.17 (0.13–0.32) | 1.01 (0.66–1.31) | < 0.001 | 0.15 (0.13–0.26) | 0.18 (0.13–0.44) | < 0.001 |
LDL-C, mmol/L | 1.85 (1.07–2.63) | 1.13 (0.38–1.74) | 2.35 (1.78-3.00) | < 0.001 | 0.77 (0.32–1.47) | 1.22 (0.52–1.93) | < 0.001 |